4//SEC Filing
Vivo Capital Fund VIII, L.P. 4
Accession 0001213900-23-089692
CIK 0001641281other
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 6:51 PM ET
Size
21.1 KB
Accession
0001213900-23-089692
Insider Transaction Report
Form 4
Vivo Capital Fund VIII, L.P.
10% Owner
Transactions
- Sale
Common Stock
2023-11-21$0.90/sh−236$212→ 269,587 total(indirect: By: Vivo Capital Surplus Fund VIII, L.P.) - Sale
Common Stock
2023-11-21$0.90/sh−1,707$1,536→ 1,952,302 total(indirect: By: Vivo Capital Fund VIII, L.P.) - Sale
Common Stock
2023-11-21$0.90/sh−1,457$1,311→ 111,662 total(indirect: By: Vivo Opportunity Fund Holdings, L.P.)
Holdings
- 1,448,286(indirect: By: Vivo Panda Fund, L.P.)
Common Stock
Vivo Panda Fund, L.P.
10% Owner
Transactions
- Sale
Common Stock
2023-11-21$0.90/sh−1,707$1,536→ 1,952,302 total(indirect: By: Vivo Capital Fund VIII, L.P.) - Sale
Common Stock
2023-11-21$0.90/sh−1,457$1,311→ 111,662 total(indirect: By: Vivo Opportunity Fund Holdings, L.P.) - Sale
Common Stock
2023-11-21$0.90/sh−236$212→ 269,587 total(indirect: By: Vivo Capital Surplus Fund VIII, L.P.)
Holdings
- 1,448,286(indirect: By: Vivo Panda Fund, L.P.)
Common Stock
Vivo Panda, LLC
10% Owner
Transactions
- Sale
Common Stock
2023-11-21$0.90/sh−1,457$1,311→ 111,662 total(indirect: By: Vivo Opportunity Fund Holdings, L.P.) - Sale
Common Stock
2023-11-21$0.90/sh−1,707$1,536→ 1,952,302 total(indirect: By: Vivo Capital Fund VIII, L.P.) - Sale
Common Stock
2023-11-21$0.90/sh−236$212→ 269,587 total(indirect: By: Vivo Capital Surplus Fund VIII, L.P.)
Holdings
- 1,448,286(indirect: By: Vivo Panda Fund, L.P.)
Common Stock
Vivo Capital VIII, LLC
10% Owner
Transactions
- Sale
Common Stock
2023-11-21$0.90/sh−1,707$1,536→ 1,952,302 total(indirect: By: Vivo Capital Fund VIII, L.P.) - Sale
Common Stock
2023-11-21$0.90/sh−1,457$1,311→ 111,662 total(indirect: By: Vivo Opportunity Fund Holdings, L.P.) - Sale
Common Stock
2023-11-21$0.90/sh−236$212→ 269,587 total(indirect: By: Vivo Capital Surplus Fund VIII, L.P.)
Holdings
- 1,448,286(indirect: By: Vivo Panda Fund, L.P.)
Common Stock
Vivo Capital Surplus Fund VIII, L.P.
10% Owner
Transactions
- Sale
Common Stock
2023-11-21$0.90/sh−1,707$1,536→ 1,952,302 total(indirect: By: Vivo Capital Fund VIII, L.P.) - Sale
Common Stock
2023-11-21$0.90/sh−236$212→ 269,587 total(indirect: By: Vivo Capital Surplus Fund VIII, L.P.) - Sale
Common Stock
2023-11-21$0.90/sh−1,457$1,311→ 111,662 total(indirect: By: Vivo Opportunity Fund Holdings, L.P.)
Holdings
- 1,448,286(indirect: By: Vivo Panda Fund, L.P.)
Common Stock
Vivo Opportunity, LLC
10% Owner
Transactions
- Sale
Common Stock
2023-11-21$0.90/sh−1,707$1,536→ 1,952,302 total(indirect: By: Vivo Capital Fund VIII, L.P.) - Sale
Common Stock
2023-11-21$0.90/sh−236$212→ 269,587 total(indirect: By: Vivo Capital Surplus Fund VIII, L.P.) - Sale
Common Stock
2023-11-21$0.90/sh−1,457$1,311→ 111,662 total(indirect: By: Vivo Opportunity Fund Holdings, L.P.)
Holdings
- 1,448,286(indirect: By: Vivo Panda Fund, L.P.)
Common Stock
Vivo Opportunity Fund Holdings, L.P.
10% Owner
Transactions
- Sale
Common Stock
2023-11-21$0.90/sh−1,707$1,536→ 1,952,302 total(indirect: By: Vivo Capital Fund VIII, L.P.) - Sale
Common Stock
2023-11-21$0.90/sh−236$212→ 269,587 total(indirect: By: Vivo Capital Surplus Fund VIII, L.P.) - Sale
Common Stock
2023-11-21$0.90/sh−1,457$1,311→ 111,662 total(indirect: By: Vivo Opportunity Fund Holdings, L.P.)
Holdings
- 1,448,286(indirect: By: Vivo Panda Fund, L.P.)
Common Stock
Footnotes (4)
- [F1]The shares are held of record by Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC is the General Partner of Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
- [F2]The shares are held of record by Vivo Capital Surplus Fund VIII, L.P. Capital VIII, LLC is the General Partner of Vivo Capital Surplus Fund VIII, L.P. Vivo Capital VIII, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
- [F3]The shares are held of record by Vivo Opportunity Fund Holdings, L.P. Vivo Opportunity, LLC is the General Partner of Vivo Opportunity Holdings, L.P. Vivo Opportunity, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
- [F4]The price reported herein is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $0.90 to $0.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (4) to this Form 4.
Documents
Issuer
Bolt Biotherapeutics, Inc.
CIK 0001641281
Entity typeother
Related Parties
1- filerCIK 0001618788
Filing Metadata
- Form type
- 4
- Filed
- Nov 21, 7:00 PM ET
- Accepted
- Nov 22, 6:51 PM ET
- Size
- 21.1 KB